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POLIOMYELITIS: PROBLEMS IN PATHOGENESIS AND IMMUNIZATION**t
The pathogenesis of poliomyelitis has been studied intensively during the
past fifty years by many investigators, yet our understanding of the course
of events in the human infection is far from perfect. There are still many
controversial issues, in general the same issues with which the early investi-
gators were also concerned: viz., is poliomyelitis an entirely neural disease,
or is there a systemic, extraneural phase? In what tissues does virus first
multiply? How does it invade the central nervous system-from the blood
or exclusively by neural pathways? What are the immune barriers against
infection and paralysis and where do they operate?
In the discussion today, I should like first to review the current status of
some of these problems, and subsequently to describe observations on
humans infected with attenuated strains of poliovirus as they relate to
certain aspects of the pathogenesis and immune mechanisms.
Current concepts of the nature of poliomyelitis lean toward an interpreta-
tion of the infection as primarily an extraneural one in which significant
CNS invasion occurs only rarely. This is not a new idea. It was in fact the
point of view expressed by Peabody, Draper, and Dochez in 191240 and by
other investigators at that time. But it was lost sight of in the enthusiasm
for neurotropic aspects of the infection which were studied so extensively in
the ensuing 25 years, largely by inoculating monkeys either intranasally or
directly into nervous tissue and employing almost exclusively the MV
strain, which had become highly neurotropic by many neural passages. The
return to a more natural perspective in terms of the human infection came
in the early 1940's, when through the work of Harmon,' Trask, Vignec,
and Paul,' Sabin and Ward,' and others, it became apparent that infection
of the alimentary tract is an important phase in the pathogenesis of polio-
myelitis. Renewed interest in the pathogenesis of poliomyelitis was stimu-
lated by the discovery beginning in 1951 that a phase of viremia occurs in
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orally infected monkeys and chimpanzees"U and also in the natural human
infection.'' Subsequently, the use of quantitative tissue culture methods of
virus and antibody assay and the many new observations by Koprowski et
al."'1 and Sabin"'e"" on humans infected with attenuated strains have con-
siderably enlarged our understanding of the pathogenesis of poliomyelitis.
There is now general agreement on the alimentary portal of entry, and it is
known that the vulnerability of different parts of the alimentary tract to
virus implantation and multiplication differs in different species. In man,
the lower intestinal tract (ileum) is more susceptible than the throat, while
the reverse is true in monkeys? and chimpanzees.'1 Sabin4e has demonstrated
that larger doses of virus are required to infect the throat than the intestinal
tract of susceptible persons; we have found the same to be true in re-
infection of naturally immune individuals.= The fact that the throat can be
by-passed-as it was in children fed attenuated virus in capsules in a human
trial to be described later-adds further evidence that multiplication of
poliovirus in the throat is not an essential part of human infection.
SITES OF PRIMARY VIRAL MULTIPLICATION
Does virus multiply first in mucosal cells or in lymphoid tissues of the
alimentary tract? Or does it avoid both of these and make its way to
regional ganglia before multiplying?
The speed with which virus appears in the throat and feces-44' in
humans after ingestion of attenuated strains-as short as 24 hours-would
seem to narrow the field to a readily available cell, either lymphoid or
epithelial. Although Faber et al.' have shown that virus inoculated directly
into ganglia can multiply and be excreted into the throat and intestinal
lumen, it would seem unlikely, as Bodian' has pointed out, that this cycle of
invasion, multiplication, and excretion could occur as rapidly as within
24 hours.
The available evidence favors a primary extraneural phase of viral
multiplication in the intestinal tract, but whether in epithelial mucosal cells or
those of the lymphoid structures or both is not clear at the present time.
The experimental evidence on early infection of the alimentary tract is
meager, being based largely on a few chimpanzees sacrificed at various
intervals after virus feeding."4 It is clear, however, that the sites with the
largest amounts of virus, presumably due to local multiplication, are the
throat and the ileum, both being areas rich in lymphatic structures. Tonsils
and Peyer's patches dissected away from pharyngeal or intestinal wall have
been assayed for virus, and in a few instances the washed wall of these areas
has also been tested. High titers have been found in the tonsils by Bodian,'
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but washed pharyngeal wall was not tested; Sabin,' on the other hand,
found high titers in the pharyngeal wall but did not test the tonsils. It is
difficult, therefore, to compare these two sets of results. Another problem is
that the complete separation of the two tissues of the alimentary tract is vir-
ually impossible. There are many submucosal collections of lymphoid cells
not necessarily as large as follicles distributed widely in the intestinal tract;
virus isolated from "washed wall" might be associated with these cells
rather than with the epithelial cells. On the other hand it is equally difficult
to rule out multiplication in epithelial cells when assaying Peyer's patches
and tonsils for virus. This is due to the fact that, as has recently been
pointed out to me by Dr. Ernest Goodpasture,'0 both of these structures
have a certain anatomical feature peculiar to them among lymphoid tissues.
This consists of the presence of deep crypts extending far into the substance
of the follicles-deep crypts which are lined with mucosal epithelial cells. In
assaying for virus it would therefore be extremely difficult to separate the
two types of tissue. One might even speculate that the localization in tonsils
and Peyer's patches in the throat and ileum is due to the presence of these
epithelial-lined recesses which form the most favorable sites for virus to
lodge, adsorb, penetrate cells both epithelial and lymphoid and begin multi-
plying. In any event, here as elsewhere in the alimentary tract, in order to
reach lymphoid cells, virus must penetrate through-or between-mucosal
cells, another reason to suspect that both tissues might support virus
growth.
The absence of lesions in either intestinal lymphoid or epithelial cells of
orally infected monkeys and chimpanzees has been regarded by Faber' as
strong evidence against their being sites of virus multiplication. This does
not seem a valid argument, since it has been demonstrated that poliomyelitis
virusM as well as others""7 can multiply in vitro to high titers in cells with-
out causing detectable alterations in cell morphology. Further, the isolation
of virus in considerable amounts from lymph nodes and intestinal wall of
chimpanzees "' indicates that multiplication in vivo can proceed without
causing visible cell damage. From the point of view of the virus, this
property of being able to live happily without disadvantage to the cells of its
human host would seem essential to survival.
Although absence of lesions of lymphoid tissues is a feature of the incuba-
tion period in the experimental disease, this is not true of fatal human
infections, for studies of lymphoid structures at autopsy have demonstrated,
in addition to virus,' mild to marked histological alterations. Comments on
the involvement of the reticulo-endothelial (R.E.) system were frequent in
papers on poliomyelitis 25 years ago. Burrows7 in 1931, on the basis of
observations on cases dying early in the course, went so far as to consider
83YALE JOURNAL OF BIOLOGY AND MEDICINE
poliomyelitis a disease of the lymphatic system, which occasionally might
involve the CNS. Landon and Smith' who reported 96 fatal cases in the
1931 New York City epidemic, probably the largest published series of
complete human autopsies, noted that "the most exaggerated picture of the
lymphatic structural involvement in poliomyelitis was that seen in the lym-
phoid tissues of the lower ileum and cecum." The changes included con-
gested, hyperplastic follicles and Peyer's patches, and in some instances
erosion and ulceration; all of these were much more striking in patients
dying early in the course rather than later in convalescence. Similar altera-
tions were found in the tonsils and spleen, but only minimal changes in the
peripheral nodes. More recently, in 1951, these findings were corroborated
by Sommers et al.,' who attempted to determine their specificity by examin-
ing lymphoid tissues from more than 50 autopsied cases of various acute
childhood infections, both viral and bacterial. In only two of these controls
were lesions detected comparable to those found in 82 per cent of polio-
myelitis cases.
Although observations on fatal human cases do not indicate what happens
in the early, primary phases of infection, yet the regular and often extensive
involvement of the lymphatic structures, taken together with evidence of
the early presence in them of virus in orally infected monkeys" and chim-
panzees," indicates that they may play an important role in the natural
infection.
VIREMIA
Although viremia has been demonstrated to occur with some regularity
in natural human infections," there is now extensive evidence that in fully
susceptible, antibody-negative individuals, viremia occurs very rarely fol-
lowing ingestion of laboratory attenuated strains.''" There is also evidence
of marked differences even between virulent strains in their capacity to
invade the blood stream. Wenner and Komitsuka" demonstrated titers as
high as 105 and 107 TCD50 per ml of blood in monkeys inoculated intra-
muscularly with a virulent Brunhilde strain of type I; in orally infected
animals, Bodian' found the Mahoney strain at levels up to 105 TCD50 in the
serum, while others, less paralytogenic, such as Y-SK (type II) and
Saukett (type III) rarely exceeded 101 TCD50.
Current problems associated with viremia include the meaning of this
relationship between virulence and degree of blood stream invasion, the
source of virus in the blood, and its significance in the pathogenesis of the
CNS infection. As to the source of virus in the blood, the speed with which
viremia can appear after oral infection with virulent strains in monkeys and
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chimpanzees (in two or three days or even less) suggests that invasion of
the blood stream occurs from sites of early multiplication either in the
alimentary tract or other extraneural tissues. Sabine3 has pointed out that it
is not likely to be the alimentary tract, since attenuated strains which multi-
ply well in the gut fail to invade the blood in significant amounts. Wenner
and Komitsukae1 demonstrated that high titers of virus can be found in the
blood and in a variety of extraneural tissues (lymph nodes, GI tract,
muscle) of cynomolgus monkeys inoculated intramuscularly with a Brun-
hilde strain of high paralytogenic capacity, and sacrificed early enough so
that only trace amounts had appeared in the CNS. In orally infected chim-
panzees sacrificed in the viremic period but before CNS invasion, Bodian8
found virus in considerable amounts in the alimentary tract, the regional
and distal lymph nodes, and the brown fat. The evidence suggests that with
virulent, paralytogenic strains, multiplication occurs extensively in various
extraneural sites and this multiplication results in viremia. With attenuated
strains, on the other hand, as Sabin has shown,' infection is more restricted,
involving chiefly the alimentary tract and regional nodes, only minimal
multiplication (if any at all) occurring more distally in the R.E. system,
spleen, peripheral nodes, and perhaps other tissues; and under these
circumstances virus fails to appear in the blood stream.
A close parallel to this course of events has been demonstrated by 0rskov
and Jensen (quoted by Madsen') for an enteric infection of mice, induced
by feeding Salmonella typhimurium. When fully virulent bacteria were fed,
it was found that the organisms could be isolated first from the lymph folli-
cles of the intestinal tract; this was followed rapidly by their appearance in
regional lymph nodes, then in more distal parts of the R.E. system, the
spleen, liver, and finally in the blood. In contrast, when mice were fed the
same strain of bacteria which had been attenuated by serial passage at high
temperatures, multiplication was demonstrated at considerable levels in
intestinal lymph follicles, to a much lesser extent than with virulent strains
in mesenteric nodes, spleen, and liver, and never was the organism cultured
from the blood. Further decrease in virulence led to infections which
involved only the intestinal lymph follicles.
A comparison of the findings on virus assay of chimpanzees infected with
attenuated strains' and virulent strains8 suggests that in poliomyelitis, as
with the enteric infection of mice studied by 0rskov and his colleagues,'
both attenuated and virulent strains multiply in the same sites but to differ-
ent extents and under different genetic controls. The loss of "invasiveness"
or "virulence" characteristic of attenuated strains is associated with a
reduced capacity to multiply in extraneural sites, which in turn is associated
with absence of viremia.4
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MECHANISMS OF CNS INVASION
The significance of viremia in poliomyelitis is a part of the problem of
how virus reaches the CNS. Does it invade directly from the blood? Or
does it travel from the periphery via nervous pathways and is viremia
merely an incidental occurrence? This also remains a controversial issue.
Actually, there is a good deal to indicate that both mechanisms may play
a role under certain circumstances. That poliovirus can travel and invade by
way of nervous tissue once inside nerve cells is a well-established fact and
has been thoroughly documented by many workers. But it does not follow
that such is the required or even the usual course of events in the natural
infection.
In summarizing the evidence favoring invasion from the blood, which
seems to me the more likely explanation, the remarkably constant associa-
tion of viremia and CNS invasiveness stands out strikingly. Although this
association does not prove that CNS virus is blood-borne, it is difficult to
relegate the correlation to a position of insignificance. Other findings which
favor CNS invasion via the blood stream include: (i) the demonstration by
German and Trask'7 of the regular occurrence of paralysis in monkeys
inoculated cutaneously into a completely denervated limb; (ii) the experi-
ments of Bodian2 in which large doses of a virulent strain of virus intro-
duced intravascularly resulted in paralysis with a short incubation period
comparable to that following intracerebral inoculation; (iii) the fact that
low levels of serum antibody produced by vaccination'5 or injection of
gamma globulin'9 protect against the paralytic disease, most probably by
blocking the viremic phase of infection.
Sabin,3 who favors the view that invasion occurs by the neural route,
believes that this blocking effect occurs not at the vascular level but at the
cellular one, and that serum antibody prevents the progress of virus from
extraneural sites of multiplication in the alimentary tract and elsewhere to
peripheral nerve endings with which the cells are in close connection.
Faber,'0 whose view is that primary multiplication takes place in ganglia and
CNS invasion occurs from peripheral neural connections, visualizes the
antibody present in mucus in the oropharynx as blocking primary neural
entry. In both Sabin's and Faber's interpretation, antibody is considered to
act at the cellular level rather than at the vascular one. If this is the case,
however, one would expect that alimentary tract infection as well as CNS
invasion would be prevented by the presence of circulating antibody. Instead,
alimentary infection has been shown to occur in the presence of even
relatively high titers of serum antibody.7"
The evidence favoring neural invasion rests largely on the demonstration
of lesions and virus in peripheral ganglia early in the course of infection
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induced by virus feeding. Faber et al. have shown this repeatedly in cyno-
molgus monkeys fed virulent strains of virus. That it is a somewhat
irregular occurrence is suggested by the results of Faber and his coworkers"
and by Bodian's findings that in only 2 of 8 chimpanzees fed virulent strains
could trace amounts be detected in trigeminal and coeliac ganglia.' Sabin
has recently reported that in a chimpanzee infected with an attenuated
strain, small amounts of virus were isolated from superior cervical and
thoracic spinal sympathetic ganglia. The interpretation of these observations
as indicative that CNS invasion necessarily occurs via neural pathways is
not convincing. Actually if, as the results indicate, both virulent and
attenuated strains may rapidly infect ganglia, this would argue that such
peripheral invasion occurs regularly but it is not an important aspect of
virulence. Obviously the data are not extensive enough to permit a final
definitive interpretation.
INFECTION IN THE PRESENCE OF ANTIBODY
Studies by Brown and his associates,' by Fox et al.,' Horstmann et al.,"
and othere"' have shown that persons who already have specific antibodies
as a result of previous natural infection do not readily become infected when
exposed to a case of poliomyelitis or poliomyelitic infection in the family.
In contrast, more than 90 per cent of susceptible, antibody-negative indi-
viduals become infected under similar circumstances. Recent field investiga-
tions have been concerned with the question, is there a qualitative difference
in the immunity resulting from natural infection as compared to that which
follows vaccination with Salk vaccine or inoculation with gamma globulin?
Brown et al.' showed that gamma-globulin-inoculated children, when ex-
posed to a case of poliomyelitis in their families, became infected and ex-
creted virus as readily as did susceptible children who had not received
gamma globulin. Similarly, several field studies carried out since 1954"'"'
indicate that vaccination with formalinized vaccine also fails to affect the
incidence of alimentary infection among vaccinees on exposure to an
infected person in the home.
This problem has also been investigated by observing the responses to
ingestion of attenuated strains of poliovirus by individuals with naturally
acquired and formalinized vaccine-induced antibodies. Koprowski et al.'
found that none of 3 individuals with antibodies to type II naturally
acquired showed antibody rises, but 2 of them excreted virus on single
occasions 5 and 23 days after ingestion of the TN type II strain. Sabin has
compared the responses of 8 "naturally immune" and 8 "vaccine immune"
persons following feeding of attenuated strains, and found that low levels
of naturally acquired antibody protected against alimentary infection,
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whereas prefeeding vaccine-acquired antibody at levels up to 256 failed to
inhibit multiplication in the alimentary tract in any of the volunteers tested.
We have been concerned with this problem, also, and have carried out
two human trials with attenuated strains generously made available to us by
Dr. Sabin. In the first one' a type III strain was fed to 5 individuals, 4 of
whom became infected. The three whose prefeeding antibody was naturally
acquired had brief periods of virus excretion in the feces 6 to 9 days, and
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FIG. 1. Age and immune status of 69 persons forming total study population.
prompt neutralizing antibody rises; the fourth individual, a vaccinated
child, excreted virus for 6 weeks, and developed CF as well as neutralizing
antibody rises. Subsequently we have carried out a trial with an attenuated
type I strain, also made available to us by Dr. Sabin who had used it previ-
ously to infect adult volunteeers. I should like to describe at this point the
results of this second trial, a preliminary report of which has already been
given. The observations represent work carried out by the Yale Poliomye-
litis Study Unit' as a team and form part of a larger program of investiga-
tion of pathogenesis and immune mechanisms in poliomyelitis.
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HUMAN TRIAL WITH ATTENUATED TYPE I POLIOVIRUS
The trial was carried out in an institution caring for mentally retarded
children. The unit used consisted of a cottage housing 69 individuals whose
ages ranged from 4 to 24 years. In general, the older individuals resided and
had their play area in the north wing, while the younger children were
largely in the south wing of the building. All of the children in the cottage
either had naturally acquired type I antibodies, or had beeen vaccinated
with commercially available Salk vaccine. Twenty were selected for virus
feeding, 10 in the vaccine-immune (V) group, and 10 in the naturally
immune (N) group-those in each group being matched for age as far as
TABLE 1.
INFECTION FOLLOWING VIRUS INGESTION, CORRELATED WITH
NATURE OF IMMUNE STATUS.
possible. It turned out later that one child who was thought to have had
low-level natural antibody was in fact fully susceptible and reacted with
a primary infection.
The strain of virus used was the attenuated L-SC, type I, generously
made available to us by Dr. Albert B. Sabin, who had previously used ali-
quots of the same lot to infect volunteers. The dosage fed to each of 20 test
subjects was 107 4TCD50. In an attempt to by-pass the throat, 7 individuals
were fed this amount mixed with polyethylene glycol 400 in hard gelatin
capsules ;* the other 13 were given the same dose in liquid form in milk.
Figure 1 indicates the residence, whether north or south side, the age, and
the antibody status of the 20 individuals fed virus, as well as of the rest of
the cottage population who formed their close associates. The older indi-
* The capsules and the polyethylene glycol were kindly supplied to us by Dr. Hilary
Koprowski, who had used the method previously in feeding virus to children.'
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RESIDENCE IMMUNE STATUS TOTAL
NATURAL VACCINE SUSCEPTIBLE INFECTED
NORTH 35 - 34
SOUTH 2/4 7/7 A 0/12
TOTAL 2/9 °/Ao 'A 13/20
(20%) (100%) (65%)
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viduals living on the north side were chiefly naturally immune; 8 of these
(5 N, 3 V) from 8-18 years of age, were fed virus. Of the south side
population, 12 (5 N, 7 V, 1 susceptible), aged 4 to 10, were fed.
Of the 20 to whom virus was administered, 13 (65 per cent became
infected (Table 1), as evidenced by virus excretion and significant antibody
rise. Two of the 9 naturally immune (20 per cent) and all 10 (100 per cent)
of the vaccine immunes thus became infected. None of the infected persons
developed signs of illness at any time.
The effect of the method of virus administration, whether by capsule or in
liquid form, is indicated in Table 2. The results confirm those of Koprowski
TABLE 2.
EFFECT OF CAPSULE OR LIQUID ADMINISTRATION OF VIRUS
ON EXCRETION FROM THROAT AND FECES
et al.' and indicate that if virus is fed in capsule form, infection of the throat
can be by-passed. None of the 7 individuals who ingested 107.4 TCD50 in
capsule form excreted virus in the throat. Four of these were natural im-
munes, only one of whom became infected as evidenced by fecal excretion.
Of the 3 capsule-fed vaccine immunes, none excreted virus in the throat, but
all excreted it in the feces. Conversely, positive throat swabs were demon-
strated in 6 of 7 vaccinees who were given virus in liquid form. In all in
whom the throat was considered infected, throat swabs were negative 6
hours after virus ingestion, but became positive 1 to 3 days later and
continued so for a matter of days.
The different patterns of virus excretion and antibody response in the
infected individuals is illustrated in Figures 2 through 5. Figure 2 shows
the results with subject #553-a 9-year-old boy, prefed naturally
90
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acquired type I antibody at a level of 1: 64.* Following ingestion of a large
dose of attenuated type I virus in capsule form, he became infected, as evi-
denced by a gradual rise in specific antibody from 64 to 1024 over a period
of 56 days. Virus excretion, however, was minimal, positive stool specimens
being obtained on the 1st and 6th days only, and the throat being con-
sistently negative. There was no significant CF response. This re-infection,
then, in a naturally immune individual resulted in barely detectable amounts
of virus in the intestinal tract, yet gave a significant (8 fold) antibody rise.
#553 - NATURAL IMMAUNE - CAPSULE FED - IO4 TCD5,
ATTENUATED TYPE I POUOVIRUS.
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64- __
6.~ .4
C.---
-- -------------------- 0
FIG. 2.
Figure 3 is also concerned with a naturally immune person who was fed
virus in liquid form. In spite of the large dose, his throat was apparently
not infected, and virus excretion in the stools was small in amount and
strikingly intermittent. His antibody rise was slow and not very high; there
was no significant CF response. The pattern is similar to that in the previ-
ous individual who also had naturally acquired antibody, and to the one
other naturally immune person who became infected: all of these had mini-
mal and intermittent excretion of virus in the feces, but definite rises in
neutralizing antibody.
Turning now to "vaccine-immune" persons who became infected: #503
* The antibody levels of all individuals reported in this study were determined by the
colorimetric neutralization test.n
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(Figure 4) with a prefeeding neutralizing antibody level of 64, was fed
virus in liquid form. He excreted virus in the throat from the 1st through
the 9th day, in the feces steadily through the 11th day, and intermittently
thereafter through the 38th day. He had a sharp rise in both neutralizing
and CF antibodies, beginning on the 10th day.
In contrast, with respect to virus in the throat, is #540 (Figure 5),
vaccine immune, but capsule fed. With a prefeeding titer of 16, this individ-
ual failed to excrete virus in the throat, but excreted it in the stools inter-
*561 - NATURAL IMMUNE - LIQUID FED 10O' TCDs
ATTENUATED TYPE I POLI0VIRUS.
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FIG. 3.
mittently from the 3d through the 21st day, in titers, usually of 3.5 to 4.5
logs per gram. Sharp rises in neutralizing and CF antibodies began on days
7 and 10. Thus, although the throat was not infected, this individual ex-
creted virus and developed antibodies as promptly as did those liquid-fed
individuals with positive throat swabs.
The patterns of response, then, of naturally immune and vaccinated
persons with more or less comparable prefeeding antibody levels who
became infected after ingestion of attenuated type I poliovirus, differed, as
illustrated in the charts (Figs. 2-5); the 2 vaccinated individuals excreted
relatively larger amounts of virus steadily during the first 2 weeks at least,
and developed rises in both neutralizing and CF antibodies; the 2 naturally
immune excreted little virus in the feces, excretion was intermittent, and
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while they developed neutralizing antibody rise, there was no significant
CF rise.
Spread of infection to associates. The next problem considered was the
ease-or difficulty-with which an attenuated strain of poliovirus might
spread to close associates of infected individuals. The population under
study consisted of 69 individuals, all living in the same cottage, but roughly
divided into two groups, the older in the North Wing and the younger in
the South Wing. Essentially the conditions of living were analogous to those
S-503- VACCINE IMMUNE - LIQUID FED le TCDs
ATTENUATED TYPE I POUOVIRUS.
DAYS O 3 7 10 14 21 28 38 45 56 70
VIRUS TITER
THROAT 3
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FIG. 4.
existing in family life, but the amount of fecal contamination of the environ-
ment was far greater because the subjects were low-grade mental defectives.
In this situation, as reported above, 13 of 20 individuals fed virus became
infected; and the degree of spread to the 49 associates was considerable
(Table 3). Among the naturally immune contacts, 1 of 36 (3 per cent)
became infected, while of the vaccine immunes the figure was 12 of 13 or
92 per cent. In all but 2 of the infected contacts, infection was evidenced by
virus excretion and antibody rise; in the 2 there was serological evidence
of infection but none of the 3 stool specimens collected at intervals of
approximately 3, 5, and 7y2 weeks after the trial began were positive for
virus. These results and these rates of spread are not comparable to those
in our previous trial' in which the type III strain used did not spread to any
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of 7 naturally immune or, one susceptible individual, all of whom were
adults, most of them living as ambulatory patients in a hospital ward. The
situation is also different from those in which Sabin4t'" has used the same
type I strain and failed to observe significant spread: his volunteers were
all adults of normal mentality.
Incubation period. The speed with which infection with the attenuated
type I virus spread to associates of individuals fed in our trial was of inter-
est in terms of the duration of the incubation period in the natural human
infection. Although stool specimens from the entire cottage were tested at
*540 -VACCINE IMMUNE - CAPSULE FED 124 TCD50
ATTENUATED TYPE I POLK0VIRUJS.
DAYS 0 3 7 10 14 21 28 38 45 5M 70
VIRUS TITER
THROAT 2
FECES 2j
TYPE I ANTIODES -NEUTRALING
1024* CF. -.. 32
256 2 *'16
64.
FIG. 5.
intervals, 14 persons (7 V, 7 N) had been selected as controls to be fol-
lowed by means of more frequent stool and blood specimens. Of the 7 vac-
cinees in the group, all became infected and in 5 the first stool collected was
already positive. This was on the 7th day after the trial had begun, i.e., 7
days after virus had been fed to the 20 test individuals. Thus the incubation
period must have been very short-2-3 days in terms of establishment of
alimentary infection since in 7 days or less 2 human passages had already
occurred. Dick and Dane9 in a recent report on a similar trial with an
attenuated strain of virus collected earlier stool specimens from contacts,
one of whom was found to be excreting virus on the 5th day after the test
individual had been fed. These observations confirm earlier estimates of
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the incubation period by Paul and others based on the occurrence of the
"abortive" or minor illness form of poliomyelitis."'
Role of antibody level in inhibiting alimentary infection. It was our aim
in this human trial to compare infection in naturally immune and vaccine-
immune individuals with comparable antibody levels, but because the
responses to Salk vaccine were not very high, this was possible in only
a limited number of instances. Table 4 correlates the occurrence of infection
with the prefeeding type I antibody titers of the 20 individuals fed and their
49 associates, in both vaccine-immune and naturally immune individuals.
TABLE 3.
SPREAD OF INFECTION AMONG 49 ASSOCIATES OF 13 INFECTED
PERSONS FED VIRUS. RELATION TO ANTIBODY STATUS.
Those vaccinees with levels up to 16 all became infected. Unfortunately,
there was none among the naturally immune with comparably low levels.
Conversely, in the group with levels of 128 or more, there were 29 among
the naturally immunes, one of whom became infected, but no comparable
group among the vaccinees. Only in the range of pre-exposure levels of 32
to 64 can an adequate comparison be made. Here, 8 of 8 (100 per cent) of
vaccinated individuals became infected, but only 2 of 15 (13 per cent) of
those who had naturally acquired antibodies. This suggests, as has been
pointed out before"'n1 that a given level of circulating antibodies alone-at
least at this 32-64 range-is not the whole story in resistance to infection;
something else, conceivably local tissue immunity or conceivably previous
high levels of antibody, alter the response.
The question of the stability of the attenuated strain of poliovirus used in
this particular trial is being studied by testing the virulence of 1st and 2d
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SOURCE OF INFECTION INFECTION OF 49 ASSOCIATES
NUMBER OF INDIVID. FED WHO IMMUNE STATUS
EXCRETED VIRUS IN FECES "NATURAL" "VACCINE"
NORTH 3 0/26 -
SOUTH 10 YVO 12/13
TOTAL 13 2/336 T /13
(3%) (92%)YALE JOURNAL OF BIOLOGY AND MEDICINE
human passage virus isolated from infected individuals late in the course of
infection. The results are as yet incomplete.
To summarize at this point the results of our trial with the L-SC attenu-
ated strain of poliovirus in this "closed" cottage population: (i) Of the 69
persons in the group, 27 eventually became infected as evidenced by virus
excretion and antibody rises. None of these persons became ill at any time
with signs suggestive of poliomyelitis. (ii) Of the 20 test individuals fed
virus, 2 of 9 or 20 per cent of the naturally immune and all 10 of the vaccine
TABLE 4.
RELATION BETWEEN ANTIBODY TITER AT TIME
OF EXPOSURE AND INFECTION IN 69 INDIVIDUALS
TYPE I ANTIBODY VACCINE IMMUNE NATURALLY IMMUNE
EXPOSURE NUMBER V% NUMBER V%
0-(4 5/5 100 (YI*) -
4-16 9 100 - T
.32-64 8/8 100 2/1s 13
128-256 V/j 20 5
512-1024 =- 0/9 0
SUSCEPTIBLE INDIVIDUAL
immunes became infected. The vaccine-immune group excreted relatively
larger amounts of virus for longer periods of time and developed CF as well
as neutralizing antibody rises. The two in the naturally immune group
excreted minimal amounts of virus intermittently, exhibited slow rises in
neutralizing antibody and no significant CF antibody response. (iii) The
throat was bypassed successfully by feeding virus in hard gelatin capsules.
Of the vaccinees, none of 3 capsule-fed individuals who became infected
excreted virus in the throat, while throat swabs were positive in 6 of 7 who
were fed the same dose in liquid form. Absence of virus in the throat did
not delay its appearance in the stools, nor was there any significant differ-
ence in antibody response between throat-positive and throat-negative indi-
viduals. (iv) Spread of infection to close associates of individuals fed virus
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occurred in 1 of 36 (3 per cent) naturally immune, and 12 of 13 (92 per
cent) vaccine-immune contacts. (v) Considering the entire trial, it was
possible to compare the ease with which infection was acquired by 15
naturally immune and 8 vaccine-immune persons with comparable type I
antibody levels (32 to 64). Two of the naturally immune (13 per cent) and
all of the vaccine immunes (100 per cent) became infected.
DISCUSSION
The results of this trial confirm certain earlier observations and provide
additional data on human responses to poliomyelitis virus infection, the
relative nature of immunity, and the existence of qualitative differences
between naturally acquired and vaccine-induced immunity.
As in previous similar studies a difference was observed in these two
groups in that individuals with naturally acquired antibody were far more
resistant to infection than were those with vaccine-acquired antibody of
approximately the same level. This difference might be explained by assum-
ing that the first line of defense is a tissue barrier ( ? local immunity) based
on one or more previous experiences of the alimentary tract with living,
multiplying virus. The second line of defense then becomes the presence of
circulating antibody. Another possible explanation is that "tissue immunity"
does not enter the picture, but there are qualitative differences in the anti-
body produced by the two different mechanisms, and higher levels of
vaccine-induced than of natural antibody are required to prevent infection
of the alimentary tract. There is some evidence that such qualitative differ-
ences do exist." Thus Sabin's so-called "low-avidity" neutralizing antibody
follows vaccination, and appears also in the acute phase of poliomyelitic
infection; in contrast is "high-avidity" antibody which is found in con-
valescence from natural infection or following infection with an attenuated
strain.' As to whether very high levels, i.e. >1000, of vaccine-induced anti-
body will offer the same protection against intestinal infection afforded by
lower levels of natural antibody, there is no direct evidence available. How-
ever, the experience of Sabine who found that three volunteers with pre-
feeding titers of 1: 256 were readily infected with an attenuated type I
strain, indicates at least that moderately high levels of vaccine-induced
antibody are not effective in this respect.
Of the many variables involved in determining responses on exposure to
polioviruses, the immune barriers and the sites at which they operate are of
primary importance in terms of immunization. The present state of
knowledge does not allow more than general conclusions about this aspect.
It is clear that circulating antibody and probably tissue barriers are involved
97YALE JOURNAL OF BIOLOGY AND MEDICINE Volume 30, November, 1957
in limiting the infectious process, in keeping it localized to the alimentary
tract and regional lymphoid structures, in preventing spread to the CNS
either from the blood stream, or along neural pathways. The effectiveness of
the blocking mechanisms is governed to a considerable extent by the viru-
lence of the infecting strain, and the dosage of virus or degree of exposure.
That naturally acquired immunity is more "solid" than vaccine-acquired
immunity seems likely, and the probability is great that it is also more
durable. Nevertheless, by enhancing the potency of the formalinized vaccine,
its effectiveness may, in the future, compare more favorably with that
achieved by natural infection. In the meantime, however, there is still much
to be learned about human responses to polioviruses. For this reason, we
believe that the pursuit of problems of active immunization with attenuated
viruses is an important area of investigation in terms of the pathogenesis of
poliomyelitis and immunization against the infection as well as the disease.
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